日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Serum Arginase-1 is a predictive biomarker for melanoma patients and a surrogate indicator of systemic myeloid cell fitness

血清精氨酸酶-1是黑色素瘤患者的预测性生物标志物,也是全身髓系细胞健康状况的替代指标。

Brand, Matthias; Adamik, Juraj; Wang, Hong; Sember, Sharon E; Muzzio, Jennifer L; Buffo, Mary J; Sander, Cindy A; Kirkwood, John M; Ferris, Robert L; Butterfield, Lisa H; Vujanovic, Lazar

Poorer survival outcomes in patients with multiple versus single primary melanoma

多发性原发性黑色素瘤患者的生存结果比单发性原发性黑色素瘤患者更差

Karapetyan, Lilit; Yang, Xi; Knight, Andrew D; Huang, Ziyu; Wang, Hong; Sander, Cindy A; Minnier, Christopher P; Wilson, Melissa; Li, Aofei; Karunamurthy, Arivarasan; Storkus, Walter J; Kirkwood, John M

Indoor tanning exposure in association with multiple primary melanoma

室内日光浴与多发性原发性黑色素瘤相关

Karapetyan, Lilit; Yang, Xi; Wang, Hong; Sander, Cindy A; Moyer, Ashley; Wilson, Melissa; Karunamurthy, Arivarasan; Kirkwood, John M

Serologic evidence of autoimmunity in E2696 and E1694 patients with high-risk melanoma treated with adjuvant interferon alfa

在接受辅助干扰素α治疗的高危黑色素瘤患者(E2696 和 E1694)中,血清学证据表明存在自身免疫

Tarhini, Ahmad A; Shin, Donghoon; Lee, Sandra J; Stuckert, Joseph; Sander, Cindy A; Kirkwood, John M

Pitfalls in retrospective analyses of biomarkers: a case study with metastatic melanoma patients.

回顾性生物标志物分析的陷阱:以转移性黑色素瘤患者为例

Potter Douglas M, Butterfield Lisa H, Divito Sherrie J, Sander Cindy A, Kirkwood John M